Cabaletta Bio, Inc. (CABA) vs Relmada Therapeutics, Inc. (RLMD)
A side-by-side comparison of Cabaletta Bio, Inc. and Relmada Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CABA
Cabaletta Bio, Inc.
$1.98HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT
RLMD
Relmada Therapeutics, Inc.
$3.34HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — CABA vs RLMD
growth of $100 · dividends reinvested · last 7yCABA -79.2% (-20.1%/yr)RLMD -35.0% (-6.0%/yr)RLMD compounded faster over this window
CABA RLMD
CABA vs RLMD: by the numbers
- •RLMD is the larger company ($350M vs $322M market cap).
Metrics side by side
Valuation
| Metric | CABA | RLMD |
|---|---|---|
| P/B ratio | 1.53 | 1.69 |
Profitability
| Metric | CABA | RLMD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -86.10% | -29.98% |
| ROIC | -85.56% | -30.78% |
Growth (annualized)
| Metric | CABA | RLMD |
|---|---|---|
| Total return CAGR (5Y) | -28.71% | -7.68% |
Frequently asked
- How have CABA and RLMD total returns compared?
- Over the past 5 years, CABA delivered -28.71% and RLMD delivered -7.68% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.